NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Gisens Biotech

Gisens Biotech

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://www.gisensbiotech.com/

Last Round

Accelerator

Aug 29, 2024

Est. Valuation

$2.61M

Total Funding Raised

$735,000

Company Overview

Gisens Biotech is a biotechnology company that develops a graphene-based point-of-care diagnostic platform for real-time health monitoring.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment, Sensors

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Non-AI

Keywords

electrochemical biosensingpoint-of-care testingPOCTdiagnostic hardwarebiomarker detectionmedical diagnosticsgraphene biosensordiagnostic consumableslab-on-a-chiprapid testingat-home diagnosticschronic kidney disease monitoringmedtechbiotech equipmentclinical decision support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gisens Biotech Comparables

Compare Gisens Biotech with similar companies based on industry and business-model similarity.

Gisens Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
StataDx, Inc.
85%
Aksense
81%
GrapheneDx
80%

Gisens Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorAug 29, 2024
AcceleratorAug 28, 2024
AcceleratorMay 16, 2023
SeedMar 1, 2023
GrantMar 2, 2021

Key People

Founding team and executive leadership

Luis Pierpauli

Co-founder CEO

Founding Team

Jose Maria Piccinini

Chief Technology Officer

Executive Team

Maria Florencia Piccinini

CFO At Gisens Biotech Director Of Outsourcing

Executive Team

Gisens Biotech Investors

Notable investors and investment history

Gisens Biotech investors
InvestorRounds
FedTechAccelerator
Activation CapitalAccelerator
gener8torAccelerator
TechstarsAccelerator
GRIDXSeed
Seven Seven SixSeed
R42 GroupSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Monthly visitors grew 92% MoM.

  • Oct 3, 2025

    Added Berkeley, a higher education institution, as a customer.

Gisens Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Gisens Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gisens Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerkeley, California
Employee Range12
Year Founded2019
Last FundingAug 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.